If you require detailed information that is not shown below, please feel free to send us an inquiry and we will get straight back to you.

Product Information

Lutetium-177 (Lu-177) is primarily used in targeted radionuclide therapy for treating neuroendocrine tumours and metastatic prostate cancer, offering effective treatment with minimal damage to healthy tissues.